American scientist's research of life's first cells

December 07, 2006

WASHINGTON, DC -- For her research of life's first cells, Irene Chen, a regional winner from North America and the Grand Prize winner, today was named to receive the $25,000 GE & Science Prize for Young Life Scientists, supported by GE Healthcare and the journal Science, which is published by AAAS, the nonprofit society.

Chen will receive her award in Stockholm, Sweden, on Monday, 11 December, during an award ceremony. She will also meet with Nobel Prize winners Andrew Fire and Craig Mello during her stay in Stockholm. Irene Chen received the grand prize for her essay, "The Emergence of Cells During the Origin of Life," which is being published in the 8 December issue of the journal Science.

"Dr. Chen has accomplished a remarkable effort at forward engineering the possible origins of cellular behavior," said Dr. Donald Kennedy, editor-in-chief of Science. "She created an evolutionary experiment among 'proto-cells' -- vesicles built of membrane materials, some of which contained RNAs functioning as enzymes whereas others did not. Some were favored competitively, demonstrating greater evolutionary fitness."

Chen describes how she has used simple "protocells" to study how life's earliest cells emerged. The protocells consist of a cell's two fundamentals: a self-replicating genome (in this case made of RNA) contained in a vesicle that separates the genome from the external environment. Chen describes how interactions between the RNA and the vesicle's membrane led to the emergence of certain basic cellular behaviors. For example, when the genome replicates inside a vesicle, osmotic pressure leads the vesicle to "steal" membrane from other, empty vesicles. This could be an example of Darwinian evolution, according to Chen. "Exploration of these minimal systems promises to lead to more exciting insights into the origins of biological complexity," she writes. Chen is currently completing medical school at Harvard and plans to continue to study molecules and evolution.

"The cell, as an evolutionary unit, could emerge from replicating molecules through very simple physical mechanisms," said Chen. "This work suggests that evolving higher levels of biological organization might have been surprisingly easy during the origin of life."

Born in San Diego, California, to Taiwanese-American parents, Chen majored in chemistry at Harvard University, and as an undergraduate studied molecular recognition in the laboratory of Gregory Verdine. She then entered the MD-PhD program and under the mentorship of Jack Szostak, she investigated the biophysics of the origin of life - work that was recognized by the Harold M. Weintraub Graduate Student Award.

"The award, now in its twelfth year, aims to recognize outstanding PhD graduate students from around the world and reward their research in the field of molecular biology," said Peter Ehrenheim, president of GE Healthcare Life Sciences. "Both Science/AAAS and GE believe that support of promising scientists at the beginning of their careers is critical for continued scientific progress."

Each year since 1995, the GE & Science Prize for Young Life Scientists has recognized outstanding young molecular biologists at an early stage of their careers. Some 54 regional winners and 12 grand prize winners have so far received the award, honoring exceptional thesis work in the field of molecular biology.

Applicants for the 2006 GE & Science Prize for Young Life Scientists earned their PhD degrees in 2005 and submitted a 1,000-word essay based on their dissertations. Their essays were judged on the quality of research and the applicants' ability to articulate how their work would contribute to the field of molecular biology, which investigates biological processes in terms of the physical and chemical properties of molecules in a cell.

A judging panel selects the GE & Science Prize for Young Life Scientists grand prize winner and may present regional awards in four geographic regions: North America, Europe, Japan and all other countries. These regional winners receive $5,000 awards. In addition to the grand prize, the 2006 awards also recognize the following regional winners:

Dianne Schwarz (North America): For her essay, "Unraveling the mysteries of small RNAs." Schwarz received a Bachelors of Science degree from the State University of New York at Albany. She did undergraduate research in the laboratory of Caro-Beth Stewart where she studied the function of short interspersed repeats in primate DNA. As a graduate student in Phillip D. Zamore's lab at the University of Massachusetts Medical School in Worcester, she characterized the RNA interference (RNAi) pathway in Drosophila and humans, and the therapeutic application of RNAi to diseases such as Amyotrophic lateral sclerosis (ALS). Schwarz' thesis work was recognized with a 2005 Harold M. Weintraub Graduate Student Award. She is currently a Jane Coffin Childs postdoctoral fellow in the lab of Erin K. O'Shea at Harvard University where she studies stress response in yeast.

Bernhard Loll (Europe): For his essay "Photosystem II, a bioenergetic nanomachine." Loll was born in Ravensburg, Germany. He studied chemistry at the Albert-Ludwigs University in Freiburg, Germany, and received his diploma degree in 2000. During his diploma he worked in the group of G.E. Schulz and this stimulated his interest in biochemistry and protein-crystallography. He continued to follow these interests by pursuing PhD work in the group of W. Saenger at the Free University Berlin, Germany. There, Loll elucidated the three dimensional structure of photosystem II, in work done in cooperation with the group of A. Zouni from Technical University Berlin. Loll defended his PhD in February 2005 and is currently a postdoctoral scientist in the group of A. Meinhart at the Max Planck Institute for Medical Research in Heidelberg, Germany.

Ron Milo (All Other Countries): For his essay "Simple Building Blocks for Complex Networks." Milo grew up in Kfar-Saba, Israel. As an undergraduate, he studied physics and mathematics at the Hebrew University in Jerusalem. His PhD research, conducted under the guidance of Uri Alon at the Weizmann Institute, centered on analyzing complex biological networks using network motifs. Milo continued in Alon's group as a postdoctoral fellow, and measured the variability and memory of protein levels in human cells. His doctoral research was recognized with a D. N. Chorafas award in 2004 and a J. F. Kennedy award in 2006. Milo is currently a fellow in the department of systems biology at Harvard medical school. In his spare time he enjoys investigating the beauty of nature in New-England together with his wife and daughter.
-end-
Science (www.sciencemag.org) is a leading international journal covering all scientific disciplines. It is published by the American Association for the Advancement of Science (AAAS), the world's largest general scientific organization. AAAS was founded in 1848, and serves 262 affiliated societies and academies of science, reaching 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The nonprofit AAAS (www.aaas.org) is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy; international programs; science education; and more. For the latest research news, log onto EurekAlert!, www.eurekalert.org, the premier science-news Web site, a service of AAAS.

GE provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring and life support systems, disease research, drug discovery and biopharmaceutical manufacturing technologies is helping physicians to detect disease earlier and to tailor personalized treatments for patients. GE Healthcare offers a broad range of products and services that are improving productivity in healthcare and enhancing patient care by enabling healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions. Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

Information about the prize and copies of the winning essays are posted on Science Online at sciencemag.org.

For more information on AAAS awards, see http://www.aaas.org/aboutaaas/awards. Awards will be bestowed at the Grand Hotel in Stockholm, Sweden on 11 December 2006.

AAAS is the world's largest general scientific society, dedicated to "Advancing science -- Serving society."

American Association for the Advancement of Science

Related Amyotrophic Lateral Sclerosis Articles from Brightsurf:

Converting lateral scanning into axial focusing to speed up 3D microscopy
In optical microscopy, high-speed volumetric imaging is limited by either the slow axial scanning rate or aberrations introduced by the z-scanning mechanism.

Ammonium triggers formation of lateral roots
Despite the importance of changes in root architecture to exploit local nutrient patches, mechanisms integrating external nutrient signals into the root developmental program remain poorly understood.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Adjustable lordotic expandable vs static lateral lumbar interbody fusion devices
The objective of this study is to compare the clinical and radiographic outcomes between patients treated with static and expandable interbody spacers with adjustable lordosis for MIS LLIF.

Chirality-assisted lateral momentum transfer for bidirectional enantioselective separation
Chiral nanoparticles which twist the light were theoretically predicted to experience lateral forces perpendicular to light vector but lacks experimental verification.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models
Scientists have delayed the onset of amyotrophic lateral sclerosis (ALS) in laboratory models, leaving them cautiously optimistic that the result, combined with other clinical advances, points to a potential treatment for ALS in humans.

Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS).

New clues about the origins of familial forms of Amyotrophic lateral sclerosis
A Brazilian study made important progress in understanding the accumulation of one of the proteins involved in amyotrophic lateral sclerosis (ALS).

Recrutement of a lateral root developmental pathway into root nodule formation of legumes
Peas and other legumes develop spherical or cylindrical structures -- called nodules -- in their roots to establish a mutually beneficial relationship with bacteria that convert atmospheric nitrogen into a useable nutrient for the legume plant.

Read More: Amyotrophic Lateral Sclerosis News and Amyotrophic Lateral Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.